Identification of ligands selective for central I2-imidazoline binding sites

Using radioligand binding techniques, several compounds selective for mammalian brain imidazoline 2 receptors have been identified. In rabbit brain membranes, a series of 6 and/or 7 aromatic-substituted derivatives of the alpha 2-adrenoceptor antagonist idazoxan were found to show moderate affinity...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurochemistry international 1997-01, Vol.30 (1), p.47-53
Hauptverfasser: Hudson, A L, Chapleo, C B, Lewis, J W, Husbands, S, Grivas, K, Mallard, N J, Nutt, D J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 53
container_issue 1
container_start_page 47
container_title Neurochemistry international
container_volume 30
creator Hudson, A L
Chapleo, C B
Lewis, J W
Husbands, S
Grivas, K
Mallard, N J
Nutt, D J
description Using radioligand binding techniques, several compounds selective for mammalian brain imidazoline 2 receptors have been identified. In rabbit brain membranes, a series of 6 and/or 7 aromatic-substituted derivatives of the alpha 2-adrenoceptor antagonist idazoxan were found to show moderate affinity for I2 receptors over alpha 2-adrenoceptors, in particular 6,7-dichloroidazoxan, which was 41 fold selective in favour of I2 receptors. Modification of the benzodioxan ring of idazoxan could also result in affinity and selectivity, which was moderate (2.7 nM, 161 fold) in the case of the 1,3-benzodioxan isomer of idazoxan (2-(1,3-benzodioxanyl)-2-imidazoline), and high (1.3 nM, 2873 fold) in the case of 2-(2-benzofuranyl-2-imidazoline) (2-BFI). Analogues of 2-BFI with halogenic substitutions of the aromatic ring were also found to retain high affinity and moderate to high selectivity for I2-sites. In particular, the 7-chloro (Ki 2.8 nM, 2192 fold) and the 4,6-dibromo (Ki 6.1 nM, 361 fold) analogues of 2-BFI. These new ligands should prove invaluable for investigating the pharmacology and physiology of I2 receptors.
doi_str_mv 10.1016/S0197-0186(96)00037-X
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78812609</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78812609</sourcerecordid><originalsourceid>FETCH-LOGICAL-c271t-18a60bbec5a2efeca5d5e5c71448309943faed8a10da5a50575619ec73f654193</originalsourceid><addsrcrecordid>eNo9kE1LAzEQhnNQaq3-hEJOoofVzO4m2Ryl-FEoeFCht5BNJiWyu6mbraC_3n7R08A7zzsDDyFTYPfAQDy8M1AyY1CJWyXuGGOFzJZnZHyKL8hlSl_bhVSMj8hIAQheyTFZzB12Q_DBmiHEjkZPm7AynUs0YYN2CD9Ifeyp3WK9aeg8z0IbnPmLTeiQ1qFzoVvRFAZMV-Tcmybh9XFOyOfz08fsNVu8vcxnj4vM5hKGDCojWF2j5SZHj9Zwx5FbCWVZFUypsvAGXWWAOcMNZ1xyAQqtLLzgJahiQm4Od9d9_N5gGnQbksWmMR3GTdKyqiAXbAfyA2j7mFKPXq_70Jr-VwPTO3N6b07vFGkl9N6cXm570-ODTd2iO7WO2op_EvdsNg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78812609</pqid></control><display><type>article</type><title>Identification of ligands selective for central I2-imidazoline binding sites</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Hudson, A L ; Chapleo, C B ; Lewis, J W ; Husbands, S ; Grivas, K ; Mallard, N J ; Nutt, D J</creator><creatorcontrib>Hudson, A L ; Chapleo, C B ; Lewis, J W ; Husbands, S ; Grivas, K ; Mallard, N J ; Nutt, D J</creatorcontrib><description>Using radioligand binding techniques, several compounds selective for mammalian brain imidazoline 2 receptors have been identified. In rabbit brain membranes, a series of 6 and/or 7 aromatic-substituted derivatives of the alpha 2-adrenoceptor antagonist idazoxan were found to show moderate affinity for I2 receptors over alpha 2-adrenoceptors, in particular 6,7-dichloroidazoxan, which was 41 fold selective in favour of I2 receptors. Modification of the benzodioxan ring of idazoxan could also result in affinity and selectivity, which was moderate (2.7 nM, 161 fold) in the case of the 1,3-benzodioxan isomer of idazoxan (2-(1,3-benzodioxanyl)-2-imidazoline), and high (1.3 nM, 2873 fold) in the case of 2-(2-benzofuranyl-2-imidazoline) (2-BFI). Analogues of 2-BFI with halogenic substitutions of the aromatic ring were also found to retain high affinity and moderate to high selectivity for I2-sites. In particular, the 7-chloro (Ki 2.8 nM, 2192 fold) and the 4,6-dibromo (Ki 6.1 nM, 361 fold) analogues of 2-BFI. These new ligands should prove invaluable for investigating the pharmacology and physiology of I2 receptors.</description><identifier>ISSN: 0197-0186</identifier><identifier>DOI: 10.1016/S0197-0186(96)00037-X</identifier><identifier>PMID: 9116587</identifier><language>eng</language><publisher>England</publisher><subject>Adrenergic alpha-Antagonists - metabolism ; Animals ; Benzofurans - chemistry ; Benzofurans - metabolism ; Brain - metabolism ; Cell Membrane - metabolism ; Female ; Idazoxan - analogs &amp; derivatives ; Idazoxan - chemistry ; Idazoxan - metabolism ; Imidazoline Receptors ; Ligands ; Male ; Rabbits ; Radioligand Assay ; Receptors, Adrenergic, alpha - metabolism ; Receptors, Drug - metabolism ; Structure-Activity Relationship</subject><ispartof>Neurochemistry international, 1997-01, Vol.30 (1), p.47-53</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c271t-18a60bbec5a2efeca5d5e5c71448309943faed8a10da5a50575619ec73f654193</citedby><cites>FETCH-LOGICAL-c271t-18a60bbec5a2efeca5d5e5c71448309943faed8a10da5a50575619ec73f654193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9116587$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hudson, A L</creatorcontrib><creatorcontrib>Chapleo, C B</creatorcontrib><creatorcontrib>Lewis, J W</creatorcontrib><creatorcontrib>Husbands, S</creatorcontrib><creatorcontrib>Grivas, K</creatorcontrib><creatorcontrib>Mallard, N J</creatorcontrib><creatorcontrib>Nutt, D J</creatorcontrib><title>Identification of ligands selective for central I2-imidazoline binding sites</title><title>Neurochemistry international</title><addtitle>Neurochem Int</addtitle><description>Using radioligand binding techniques, several compounds selective for mammalian brain imidazoline 2 receptors have been identified. In rabbit brain membranes, a series of 6 and/or 7 aromatic-substituted derivatives of the alpha 2-adrenoceptor antagonist idazoxan were found to show moderate affinity for I2 receptors over alpha 2-adrenoceptors, in particular 6,7-dichloroidazoxan, which was 41 fold selective in favour of I2 receptors. Modification of the benzodioxan ring of idazoxan could also result in affinity and selectivity, which was moderate (2.7 nM, 161 fold) in the case of the 1,3-benzodioxan isomer of idazoxan (2-(1,3-benzodioxanyl)-2-imidazoline), and high (1.3 nM, 2873 fold) in the case of 2-(2-benzofuranyl-2-imidazoline) (2-BFI). Analogues of 2-BFI with halogenic substitutions of the aromatic ring were also found to retain high affinity and moderate to high selectivity for I2-sites. In particular, the 7-chloro (Ki 2.8 nM, 2192 fold) and the 4,6-dibromo (Ki 6.1 nM, 361 fold) analogues of 2-BFI. These new ligands should prove invaluable for investigating the pharmacology and physiology of I2 receptors.</description><subject>Adrenergic alpha-Antagonists - metabolism</subject><subject>Animals</subject><subject>Benzofurans - chemistry</subject><subject>Benzofurans - metabolism</subject><subject>Brain - metabolism</subject><subject>Cell Membrane - metabolism</subject><subject>Female</subject><subject>Idazoxan - analogs &amp; derivatives</subject><subject>Idazoxan - chemistry</subject><subject>Idazoxan - metabolism</subject><subject>Imidazoline Receptors</subject><subject>Ligands</subject><subject>Male</subject><subject>Rabbits</subject><subject>Radioligand Assay</subject><subject>Receptors, Adrenergic, alpha - metabolism</subject><subject>Receptors, Drug - metabolism</subject><subject>Structure-Activity Relationship</subject><issn>0197-0186</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1LAzEQhnNQaq3-hEJOoofVzO4m2Ryl-FEoeFCht5BNJiWyu6mbraC_3n7R08A7zzsDDyFTYPfAQDy8M1AyY1CJWyXuGGOFzJZnZHyKL8hlSl_bhVSMj8hIAQheyTFZzB12Q_DBmiHEjkZPm7AynUs0YYN2CD9Ifeyp3WK9aeg8z0IbnPmLTeiQ1qFzoVvRFAZMV-Tcmybh9XFOyOfz08fsNVu8vcxnj4vM5hKGDCojWF2j5SZHj9Zwx5FbCWVZFUypsvAGXWWAOcMNZ1xyAQqtLLzgJahiQm4Od9d9_N5gGnQbksWmMR3GTdKyqiAXbAfyA2j7mFKPXq_70Jr-VwPTO3N6b07vFGkl9N6cXm570-ODTd2iO7WO2op_EvdsNg</recordid><startdate>199701</startdate><enddate>199701</enddate><creator>Hudson, A L</creator><creator>Chapleo, C B</creator><creator>Lewis, J W</creator><creator>Husbands, S</creator><creator>Grivas, K</creator><creator>Mallard, N J</creator><creator>Nutt, D J</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199701</creationdate><title>Identification of ligands selective for central I2-imidazoline binding sites</title><author>Hudson, A L ; Chapleo, C B ; Lewis, J W ; Husbands, S ; Grivas, K ; Mallard, N J ; Nutt, D J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c271t-18a60bbec5a2efeca5d5e5c71448309943faed8a10da5a50575619ec73f654193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Adrenergic alpha-Antagonists - metabolism</topic><topic>Animals</topic><topic>Benzofurans - chemistry</topic><topic>Benzofurans - metabolism</topic><topic>Brain - metabolism</topic><topic>Cell Membrane - metabolism</topic><topic>Female</topic><topic>Idazoxan - analogs &amp; derivatives</topic><topic>Idazoxan - chemistry</topic><topic>Idazoxan - metabolism</topic><topic>Imidazoline Receptors</topic><topic>Ligands</topic><topic>Male</topic><topic>Rabbits</topic><topic>Radioligand Assay</topic><topic>Receptors, Adrenergic, alpha - metabolism</topic><topic>Receptors, Drug - metabolism</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hudson, A L</creatorcontrib><creatorcontrib>Chapleo, C B</creatorcontrib><creatorcontrib>Lewis, J W</creatorcontrib><creatorcontrib>Husbands, S</creatorcontrib><creatorcontrib>Grivas, K</creatorcontrib><creatorcontrib>Mallard, N J</creatorcontrib><creatorcontrib>Nutt, D J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neurochemistry international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hudson, A L</au><au>Chapleo, C B</au><au>Lewis, J W</au><au>Husbands, S</au><au>Grivas, K</au><au>Mallard, N J</au><au>Nutt, D J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of ligands selective for central I2-imidazoline binding sites</atitle><jtitle>Neurochemistry international</jtitle><addtitle>Neurochem Int</addtitle><date>1997-01</date><risdate>1997</risdate><volume>30</volume><issue>1</issue><spage>47</spage><epage>53</epage><pages>47-53</pages><issn>0197-0186</issn><abstract>Using radioligand binding techniques, several compounds selective for mammalian brain imidazoline 2 receptors have been identified. In rabbit brain membranes, a series of 6 and/or 7 aromatic-substituted derivatives of the alpha 2-adrenoceptor antagonist idazoxan were found to show moderate affinity for I2 receptors over alpha 2-adrenoceptors, in particular 6,7-dichloroidazoxan, which was 41 fold selective in favour of I2 receptors. Modification of the benzodioxan ring of idazoxan could also result in affinity and selectivity, which was moderate (2.7 nM, 161 fold) in the case of the 1,3-benzodioxan isomer of idazoxan (2-(1,3-benzodioxanyl)-2-imidazoline), and high (1.3 nM, 2873 fold) in the case of 2-(2-benzofuranyl-2-imidazoline) (2-BFI). Analogues of 2-BFI with halogenic substitutions of the aromatic ring were also found to retain high affinity and moderate to high selectivity for I2-sites. In particular, the 7-chloro (Ki 2.8 nM, 2192 fold) and the 4,6-dibromo (Ki 6.1 nM, 361 fold) analogues of 2-BFI. These new ligands should prove invaluable for investigating the pharmacology and physiology of I2 receptors.</abstract><cop>England</cop><pmid>9116587</pmid><doi>10.1016/S0197-0186(96)00037-X</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0197-0186
ispartof Neurochemistry international, 1997-01, Vol.30 (1), p.47-53
issn 0197-0186
language eng
recordid cdi_proquest_miscellaneous_78812609
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adrenergic alpha-Antagonists - metabolism
Animals
Benzofurans - chemistry
Benzofurans - metabolism
Brain - metabolism
Cell Membrane - metabolism
Female
Idazoxan - analogs & derivatives
Idazoxan - chemistry
Idazoxan - metabolism
Imidazoline Receptors
Ligands
Male
Rabbits
Radioligand Assay
Receptors, Adrenergic, alpha - metabolism
Receptors, Drug - metabolism
Structure-Activity Relationship
title Identification of ligands selective for central I2-imidazoline binding sites
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T18%3A57%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20ligands%20selective%20for%20central%20I2-imidazoline%20binding%20sites&rft.jtitle=Neurochemistry%20international&rft.au=Hudson,%20A%20L&rft.date=1997-01&rft.volume=30&rft.issue=1&rft.spage=47&rft.epage=53&rft.pages=47-53&rft.issn=0197-0186&rft_id=info:doi/10.1016/S0197-0186(96)00037-X&rft_dat=%3Cproquest_cross%3E78812609%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78812609&rft_id=info:pmid/9116587&rfr_iscdi=true